newsfilter
← Latest News
GlobeNewswire·

A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology

Issued on behalf of GT Biopharma, Inc. From bispecific ADCs at IDEAYA to a GSK partnership at Summit, B7-H3 has become one of the most actively pursued antigens in solid tumor oncology — and a new natural killer cell